169 related articles for article (PubMed ID: 8879874)
1. Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma.
Deshmukh A; Scott JA; Palmer EL; Hochberg FH; Gruber M; Fischman AJ
Clin Nucl Med; 1996 Sep; 21(9):720-5. PubMed ID: 8879874
[TBL] [Abstract][Full Text] [Related]
2. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
[TBL] [Abstract][Full Text] [Related]
3. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain.
Buchpiguel CA; Alavi JB; Alavi A; Kenyon LC
J Nucl Med; 1995 Jan; 36(1):159-64. PubMed ID: 7799071
[TBL] [Abstract][Full Text] [Related]
4. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T
Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028
[TBL] [Abstract][Full Text] [Related]
5. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
[TBL] [Abstract][Full Text] [Related]
7. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma.
Fischman AJ; Thornton AF; Frosch MP; Swearinger B; Gonzalez RG; Alpert NM
J Nucl Med; 1997 Jul; 38(7):1027-9. PubMed ID: 9225785
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography.
Doyle WK; Budinger TF; Valk PE; Levin VA; Gutin PH
J Comput Assist Tomogr; 1987; 11(4):563-70. PubMed ID: 3496366
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032
[TBL] [Abstract][Full Text] [Related]
10. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
Kim EE; Chung SK; Haynie TP; Kim CG; Cho BJ; Podoloff DA; Tilbury RS; Yang DJ; Yung WK; Moser RP
Radiographics; 1992 Mar; 12(2):269-79. PubMed ID: 1561416
[TBL] [Abstract][Full Text] [Related]
12. Tl-201 SPECT and F-18 FDG PET for assessment of glioma recurrence versus radiation necrosis.
Siepmann DB; Siegel A; Lewis PJ
Clin Nucl Med; 2005 Mar; 30(3):199-200. PubMed ID: 15722830
[No Abstract] [Full Text] [Related]
13. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Stokkel M; Stevens H; Taphoorn M; Van Rijk P
Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
[TBL] [Abstract][Full Text] [Related]
14. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.
Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T
Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817
[TBL] [Abstract][Full Text] [Related]
16. PET-FDG of pleomorphic xanthoastrocytoma.
Bicik I; Raman R; Knightly JJ; Di Chiro G; Fulham MJ
J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
18. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.
Di Chiro G; Oldfield E; Wright DC; De Michele D; Katz DA; Patronas NJ; Doppman JL; Larson SM; Ito M; Kufta CV
AJR Am J Roentgenol; 1988 Jan; 150(1):189-97. PubMed ID: 3257119
[TBL] [Abstract][Full Text] [Related]
19. Glucose consumption in recurrent gliomas.
Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
[TBL] [Abstract][Full Text] [Related]
20. Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG.
Mogard J; Kihlström L; Ericson K; Karlsson B; Guo WY; Stone-Elander S
J Comput Assist Tomogr; 1994; 18(2):177-81. PubMed ID: 8126264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]